Allarity Therapeutics Inc (ALLR) Stock Price, Quote & News

Company Profile

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2...

Industry: Biotechnology

Sector: Healthcare

Phone: 401 426 4664

Website: www.allarity.com

Address:

24 School Street, 2nd Floor, Boston, United States

PhantumTrader Oct. 24 at 10:18 PM

$ALLR would love to grab this under $1 again if it went there

1 · Reply

Nymn Oct. 24 at 4:55 PM

$ALLR @somaopp It’ll happen with the buyout! 👍

1 · Reply

ka1954 Oct. 24 at 2:56 PM

$ALLR piece of crap. when market goes up, it doesn't affect the stock but when market goes down, ALLR went down with it.

1 · Reply

Rimawi4 Oct. 24 at 2:21 PM

$ALLR Feom this point it will go up inshaallah

0 · Reply

BitcoinFuture Oct. 23 at 7:56 PM

$ALLR it’s trying to fill that gap first! It’s long term for me anyways. They are definitely shopping a buyout. Just hold and you’ll be rewarded.

2 · Reply

ka1954 Oct. 23 at 4:31 PM

$ALLR if a stock like BYND can go from .50 to 7.50 in a week just because they didn't declare bankruptcy and rather did heavy dilution, then nothing means anything. only thing matter is that if stock is hyped enough then some traders can take up ur stock 1000% very easily. i don't know what will hype ALLR stock

0 · Reply

Ugly1 Oct. 23 at 3:23 PM

$ALLR just incredible how pitiful, wtf is actually going on with this company? I’m starting to worry about their intentions/ next move. It’s getting harder to trust what’s next…narrative always “sounds good”, but will it ever deliver any fruit??? Hope is not a great strategy…

0 · Reply

Carny Oct. 23 at 2:43 PM

$ALLR well thought it would hold 1.50 but looks like the slow and steady blead back to $1. this was the slowest pump and dump in its history I think😁

1 · Reply

TargasMum Oct. 22 at 4:44 PM

$ALLR Jensen has the power to make this fly and instead he’s all radio silence. Jensen reeks of Peter Principle!!! Seriously sick of this nonsense. Fire Jensen and get someone that is proactive and not just collecting a fat salary.

1 · Reply

somaopp Oct. 22 at 3:38 PM

$ALLR its time mgmt acted to make this realize its true worth, find someone who could lead this to it..

1 · Reply

Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months

Sep 17, 2025, 8:00 AM EDT - 5 weeks ago

Allarity Therapeutics CEO to Present at Biomarkers & Precision Medicine 2025

Aug 26, 2025, 8:00 AM EDT - 2 months ago

Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer

Aug 15, 2025, 4:30 PM EDT - 2 months ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

Jul 15, 2025, 8:00 AM EDT - 3 months ago

Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization

Jul 7, 2025, 8:00 AM EDT - 3 months ago

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer

Jun 27, 2025, 8:00 AM EDT - 4 months ago

Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer

Jun 11, 2025, 4:05 PM EDT - 4 months ago

Allarity Therapeutics Announces Changes to Board of Directors

May 9, 2025, 4:05 PM EDT - 6 months ago

Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment

Apr 14, 2025, 9:04 AM EDT - 6 months ago

ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Mar 14, 2025, 4:30 AM EDT - 8 months ago

ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Mar 13, 2025, 8:30 AM EDT - 8 months ago

Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission

Mar 6, 2025, 8:00 AM EST - 8 months ago

Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration

Feb 24, 2025, 8:00 AM EST - 8 months ago

Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients

Feb 14, 2025, 10:00 AM EST - 9 months ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 13, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Shareholders to Inquire about Securities Investigation

Feb 12, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Connect

Feb 11, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Reach Out

Feb 10, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Stockholders to Inquire about Securities Investigation

Feb 9, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Investors to Learn More About the Investigation

Feb 7, 2025, 10:00 AM EST - 9 months ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 6, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Connect

Feb 6, 2025, 8:00 AM EST - 9 months ago

Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer

Feb 4, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Investors to Inquire about Securities Investigation

Feb 3, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Reach Out

Feb 2, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Reach Out

Jan 31, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Connect

Jan 30, 2025, 8:00 AM EST - 9 months ago

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC

Jan 8, 2025, 10:00 AM EST - 10 months ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jan 5, 2025, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Stockholders to Learn More About the Investigation

Nov 18, 2024, 8:00 AM EST - 1 year ago

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

Nov 11, 2024, 3:45 PM EST - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Nov 11, 2024, 11:15 AM EST - 1 year ago

DEADLINE TOMORROW: Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Reach Out To The Schall Law Firm

Nov 9, 2024, 12:30 PM EST - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Contact The Schall Law Firm

Nov 8, 2024, 7:00 PM EST - 1 year ago

ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Nov 8, 2024, 9:45 AM EST - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Nov 7, 2024, 11:00 AM EST - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Should Contact The Schall Law Firm

Nov 6, 2024, 11:00 AM EST - 1 year ago

The Schall Law Firm Encourages Stockholder Participation In A Case Against Allarity Therapeutics, Inc. For Fraud

Nov 4, 2024, 11:00 AM EST - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Help The Schall Law Firm

Nov 2, 2024, 11:00 AM EDT - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm

Oct 29, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Stockholders To Join A Lawsuit Against Allarity Therapeutics, Inc. For Fraud

Oct 27, 2024, 11:00 AM EDT - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

PhantumTrader Oct. 24 at 10:18 PM

$ALLR would love to grab this under $1 again if it went there

1 · Reply

Nymn Oct. 24 at 4:55 PM

$ALLR @somaopp It’ll happen with the buyout! 👍

1 · Reply

ka1954 Oct. 24 at 2:56 PM

$ALLR piece of crap. when market goes up, it doesn't affect the stock but when market goes down, ALLR went down with it.

1 · Reply

Rimawi4 Oct. 24 at 2:21 PM

$ALLR Feom this point it will go up inshaallah

0 · Reply

BitcoinFuture Oct. 23 at 7:56 PM

$ALLR it’s trying to fill that gap first! It’s long term for me anyways. They are definitely shopping a buyout. Just hold and you’ll be rewarded.

2 · Reply

ka1954 Oct. 23 at 4:31 PM

0 · Reply

Ugly1 Oct. 23 at 3:23 PM

0 · Reply

Carny Oct. 23 at 2:43 PM

$ALLR well thought it would hold 1.50 but looks like the slow and steady blead back to $1. this was the slowest pump and dump in its history I think😁

1 · Reply

TargasMum Oct. 22 at 4:44 PM

1 · Reply

somaopp Oct. 22 at 3:38 PM

$ALLR its time mgmt acted to make this realize its true worth, find someone who could lead this to it..

1 · Reply

MichaelSctock Oct. 22 at 2:35 PM

$ALLR Fire sale 🔥

1 · Reply

johnny6nine Oct. 22 at 12:43 PM

$ALLR $MRKR $GLMD painful.

0 · Reply

Dizzier47 Oct. 22 at 11:23 AM

$ALLR dump a bit more so i can get in again

0 · Reply

Nymn Oct. 21 at 9:22 PM

$ALLR Holding. $5 minimum. ⬆️

0 · Reply

Ugly1 Oct. 21 at 6:27 PM

$ALLR this mf needs to do something already, I’m dying to get out of it, but not giving it away as I know there’s so much unrealized value.

1 · Reply

tlsdydaks Oct. 21 at 8:16 AM

$ALLR 믿고 기다리기가 힘들다 다들 어떻게 믿고 투자하는거야? 나에게 힘을줘~ 물을 타야하는거야?

2 · Reply

MichaelSctock Oct. 20 at 5:09 PM

$CTXR feels good to be the best! $ALLR you ready? 🍻

1 · Reply

Mikess1 Oct. 20 at 3:27 PM

$ALLR going to be slow until we get the next bit of news 😴

1 · Reply

AlwaysBeHumble Oct. 19 at 11:26 PM

$VRME gapper incoming over night. $BYND $ALLR $LNKS $TOVX

0 · Reply

sharetp02 Oct. 17 at 7:54 PM

$ALLR - Idk whats up with this bio-tech. They seem promising but sitting at the same price all year. Well, increased by .58

1 · Reply

somaopp Oct. 17 at 12:52 PM

$ALLR hope no further slide?? everything is fine except perhaps need mgmt change to realize stock holder value??

1 · Reply

ka1954 Oct. 16 at 6:28 PM

$ALLR piece of crap. it didn't do anyting for last 2 months when market was going up. and now goinig down just because market is in correction mode

1 · Reply

Market Cap	20.19M
Revenue (ttm)	0.00
Net Income (ttm)	-24.52M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.11

Volume	274,800
Avg Vol	8,892,351
Day's Range	N/A - N/A
Shares Out	14.52M
Stochastic %K	23%
Beta	0.22
Analysts	Sell
Price Target	$9.25